Academic & Industry Advisors
Principal Investigator, Cancer Immunology & Virology, Dana-Farber Cancer Institute
Associate Professor, Dana-Farber Cancer Institute & Harvard Medical School
Associate Member, Broad Institute of Harvard/MIT
Founder, SanaRx BioTherapeutics
Founder, Dynamic Cell Tx
Entrepreneur in Residence, Dana-Farber Cancer Institute
Founder and Partner of Ascentia Asset Management, Inc.
Founder and Former CEO/President of Javelin Pharmaceuticals, Inc.
Chairman, Courage Tx
Special Advisor for Technology Development at Dana-Farber
Former Director of Dana-Farber Translational Research Laboratory
Chief Medical Officer, Alnylam Pharmaceuticals
Vice President, Research at Tekla Capital Management
Sr. Director, Head of Business Development, Strategic Partnerships, CANbridge Pharmaceuticals Inc.
Principal, Binney Street Capital
Co-Founder, NextRNA Therapeutics
Co-Founder, SAB Member, SanaRx Biotherapeutics
Student Leadership
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Research Fellow, Cancer Genetics, Dana-Farber Cancer Institute and Harvard Medical School
PhD Candidate, Neuroscience, Harvard University
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Past Student Leadership
Director (2022-2023)
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Associate Director (2022-2023)
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Associate Director (2019-2021)
Master of Bioethics candidate, Harvard Medical School; Chief Product Officer, FOXO
Associate Director (2022-2024)
Research Fellow, Neurology, Massachusetts General Hospital and Harvard Medical School